Symbole | YTM % | Volume | Prix % | Coupon % | Date d'échéance | Montant en suspens | Valeur nominale | Montant min de la dénomination | Émetteur |
---|---|---|---|---|---|---|---|---|---|
TKPH5841810Takeda Pharmaceutical Company Limited 5.8% 05-JUL-2064 | 5,66% | 13,335 M | 102,68% | 5,80% | 2064-07-05 | 500 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 5,63% | 188 K | 95,05% | 5,25% | 2045-06-23 | 500,407 M USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
TKPH5841809Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2054 | 5,56% | 9,93 M | 101,46% | 5,65% | 2054-07-05 | 600 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TKPH5841808Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2044 | 5,44% | 1,6 M | 102,66% | 5,65% | 2044-07-05 | 800 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TKPH5010046Takeda Pharmaceutical Company Limited 3.025% 09-JUL-2040 | 5,40% | 2 M | 73,83% | 3,03% | 2040-07-09 | 1,5 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TKPH5010047Takeda Pharmaceutical Company Limited 3.175% 09-JUL-2050 | 5,15% | 655 K | 69,46% | 3,18% | 2050-07-09 | 2 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TKPH5841807Takeda Pharmaceutical Company Limited 5.3% 05-JUL-2034 | 5,12% | 14,55 M | 101,39% | 5,30% | 2034-07-05 | 1,1 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TKPH5010048Takeda Pharmaceutical Company Limited 3.375% 09-JUL-2060 | 5,12% | 992 K | 67,53% | 3,38% | 2060-07-09 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TKPH5010045Takeda Pharmaceutical Company Limited 2.05% 31-MAR-2030 | 4,74% | 3,371 M | 87,16% | 2,05% | 2030-03-31 | 2,5 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TKPH4770188Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | 4,71% | 15 K | 101,07% | 5,00% | 2028-11-26 | 1,727 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 | 4,59% | 0 | 97,50% | 3,20% | 2026-09-23 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Shire Acquisitions Investments Ireland DAC |
TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 | 4,52% | 378 K | 99,49% | 4,00% | 2025-06-23 | 800,169 M USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
TKDBTAKEDA PHARMA. 20/40 | 3,75% | 0 | 78,78% | 2,00% | 2040-07-09 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
XS219734964TAKEDA PHARMA. 20/32 | 3,26% | 0 | 87,15% | 1,38% | 2032-07-09 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
XS184344939TAKEDA PHARMA.18/30 REGS | 3,14% | 0 | 99,21% | 3,00% | 2030-11-21 | 1,5 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
XS219734859TAKEDA PHARMA. 20/29 | 2,90% | 0 | 91,69% | 1,00% | 2029-07-09 | 850 M EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
XS184344912TAKEDA PHARMA. 18/26 REGS | 2,75% | 0 | 99,01% | 2,25% | 2026-11-21 | 1,5 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
XS219734832TAKEDA PHARMA. 20/27 | 2,74% | 0 | 94,88% | 0,75% | 2027-07-09 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
TKPH4770186Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | 0,84% | 0 | 116,57% | 5,00% | 2028-11-26 | 22,685 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 | — | — | — | 4,00% | 2025-06-23 | 303 K USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
TKPH4770187Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | — | — | — | 5,00% | 2028-11-26 | 22,685 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |